VIR BIOTECHNOLOGY INC (VIR:NASDAQ)
$10.75 0.42 (4.0658%)
Analysed VIR BIOTECHNOLOGY INC (VIR:NASDAQ) News Sources
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
16-04-2026
yahoo.com
A Look At Vir Biotechnology (VIR) Valuation After New VIR-5500 Prostate Cancer Trial Milestone
14-04-2026
yahoo.com
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
13-04-2026
yahoo.com
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000
12-04-2026
fool.com
Vir Biotechnology (VIR) Leading with Its BiTEs Therapy
10-04-2026
yahoo.com
Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus
28-02-2026
yahoo.com
Vir Biotechnology to Participate in Upcoming Investor Conferences
26-02-2026
yahoo.com
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
26-02-2026
yahoo.com
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
26-02-2026
yahoo.com
Company News for Feb 25, 2026
25-02-2026
yahoo.com
What is the current price of VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The current price of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is $10.75.
VIR BIOTECHNOLOGY INC (VIR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) since the previous trading day is $0.42.
VIR BIOTECHNOLOGY INC (VIR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) since the previous trading day is 4.0658%.
What is the most recent average sentiment score for VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The most recent average sentiment score for VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The most recent sentiment for VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is .
SEC-8K** Filing Available For VIR BIOTECHNOLOGY INC (VIR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.